CLASS II ONGOING Device recall · Reported 15 Oct 2025 · FDA Enforcement Report

FlexLab (FLX) System recalled by Inpeco

Inpeco is recalling FlexLab (FLX) System, distributed in California, New York. The recall was initiated on 3 Sep 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesPN: FLX-056-01, FLX-056-11; UDI: 07640172340004: Serial No. FLX.0204, FLX.0205, FLX.0209, FLX.0210, FLX.0216, FLX.0220, FLX.0221, FLX.0222.
Quantity recalled8 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0106-2026
FDA event ID
97565
Recalling firm
Inpeco, Lugano
Classification
Class II
Status
Ongoing
Recall initiated
3 Sep 2025
FDA classified
9 Oct 2025
Reported
15 Oct 2025
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Other Reasons

Timeline

3 Sep 2025Recall initiated by company
9 Oct 2025Classified by FDA+36 days
15 Oct 2025Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The FlexLab System Sample Integrity Module (SIM) includes function that determines the hemolysis, icterus, and lipemia (HIL) in blood samples. This function has not been evaluated for safety and effectiveness by the FDA, so its use may cause an increase in erroneous results or a delay in patient results.

Product as listed by the FDA

FlexLab (FLX) System. Potassium Test System. in vitro diagnostic

Where it was distributed

US distribution to CA & NY.

CaliforniaNew York

Questions about this recall

Why was it recalled?

The FlexLab System Sample Integrity Module (SIM) includes function that determines the hemolysis, icterus, and lipemia (HIL) in blood samples. This function has not been evaluated for safety and effectiveness by the FDA, so its use may cause an increase in erroneous results or a delay in patient results.

Which lots are affected?

PN: FLX-056-01, FLX-056-11; UDI: 07640172340004: Serial No. FLX.0204, FLX.0205, FLX.0209, FLX.0210, FLX.0216, FLX.0220, FLX.0221, FLX.0222.

Where was it sold?

US distribution to CA & NY.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 97565

This product is part of a recall event; the main page for the event is FlexLab X (FXX) System recalled by Inpeco.

ReportedClassRecallCompanyReasonWhere
CLASS IIFlexLab X (FXX) System recalled by InpecoInpecoOtherCA, NY

More recalls from Inpeco

All 33
ReportedClassRecallCompanyReasonWhere
DeviceCLASS IIFlexLab (FLX) recalled by InpecoInpecoOtherMI
DeviceCLASS IIFlexLab (FLX) recalled by InpecoInpecoOtherMI
DeviceCLASS IIFlexLab X (FXX) System recalled by InpecoInpecoOtherCA, NY
DeviceCLASS IIRoche Cobas 8000 and Cobas PRO Interface Module recalled by InpecoInpecoOtherNationwide
DeviceCLASS IIFlexLab (FLX), Accelerator a3600 (ACP), Aptio Automation recalledInpecoDevice MalfunctionNationwide

Other Test Kits & Diagnostics recalls

All 2,663